Safe liver resection following chemotherapy for colorectal metastases is a matter of timing

Neoadjuvant chemotherapy (NC) can improve the resectability of hepatic colorectal metastases (CRM). However, there is concern regarding its impact on operative risk. We reviewed 750 consecutive liver resections performed for CRM in a single unit (1996–2005) to evaluate whether NC affected morbidity...

Descripción completa

Detalles Bibliográficos
Autores principales: Welsh, F K S, Tilney, H S, Tekkis, P P, John, T G, Rees, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360122/
https://www.ncbi.nlm.nih.gov/pubmed/17353923
http://dx.doi.org/10.1038/sj.bjc.6603670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360122/
https://www.ncbi.nlm.nih.gov/pubmed/17353923
http://dx.doi.org/10.1038/sj.bjc.6603670

Ejemplares similares